In order to succeed, biotech, drug, and device companies must publish their results in peer-reviewed journals in an effort to add value to promote and commercialize their technologies. The drivers of this exercise include reimbursement, credibility, commercialization and valuations. If you’re not publishing, you’re missing out on valuable opportunities to improve the chances for your company to succeed.
In this interactive program, you will learn the how, why and when of a successful publication strategy. Experts in the field will be joined by professionals who have effectively implemented the process. You will learn from their successes and failures.
Topics to be covered:
- When, where and what to publish
- Timing of publications throughout the product development cycle
- Article types to consider, and why; look at both home runs and base hits
- How peer-reviewed publications support reimbursement strategy
- Developing a roadmap to maximize publication objectives
- PR and your publication program
The program will include case examples and a sample roadmap for success.
Joel Batts | Partner, Telos Partners, LLC read bio»
Tom Michal | Worldwide VP of Market Access, Health Economics & Reimbursement, ReWalk Robotics, Inc. read bio»
Samir Bhattacharyya | Head, Health Economics and Market Access, US Depuy Synthes read bio»
3:30 PM | Registration and Networking
4:00 PM | Presentation
4:30 PM | Q&A
5:00 PM | Panel Discussion
5:45 PM | Q&A
6:00 PM | Food and Networking
7:00 PM | Program Close
$25 | General Public
$15 | Student/Academic
$45 | At the door
JLABS @ LabCentral
700 Main Street
Joel Batts, MA | Partner at Telos Partners, LLC
Joel is a medical device industry veteran, with 20 years of leadership experience developing scientific and regulatory strategies for start-ups to large cap companies. He has delivered >$100 million return on investment by delivering FDA approvals for Class II and Class III devices in the musculoskeletal and wound care spaces. He has published and presented the results of pre-clinical and clinical science in journals such as American Journal of Sports Medicine, American Journal of Orthopaedics, and venues such as the American College of Foot and Ankle Surgeons. In 2010, he led a business development team in the application of a novel biologic material to osteoporotic patients for reducing the incidence of hip fractures. After conducting early-phase trials and developing the scientific and regulatory, the team sold the technology for $30 million. He has also overseen key areas of investment and integration for four major acquisitions. Outside of Telos Partners, Joel is part of a LifeNet International, a non-profit that is transforming healthcare in African communities. Joel earned a BS in exercise science from the University of Florida and an MA in bioethics and health policy from Loyola University Chicago.
Connect with Joel:
Tom Michal | Worldwide VP of Market Access, Health Economics & Reimbursement, ReWalk Robotics, Inc.
Tom has over 2 decades of healthcare experience with emphasis on market assessment, health economics, global reimbursement and government relations. He is a recognized expert in coding, coverage, and payment initiatives in start-up environments, as well as enterprise-level biomedical firms. As a specialist in market access and early commercialization, Tom has been responsible for guiding company efforts in key global markets in an effort to drive innovative technology adoption. Tom has developed numerous publication planning and presentation strategies in an effort to create the appropriate “messaging” that supports product claims and long term commercialization objectives.
Samir Bhattacharyya, PhD, MS, MSc | Head, Health Economics and Market Access, US Depuy Synthes
Dr. Samir Bhattacharyya has 19 years of global experience in the medical device, pharmaceutical, and biotechnology industries. He held leadership positions with increasing responsibilities in sales & marketing, pricing & reimbursement, health economics & market access, and clinical research & development. Dr. Bhattacharyya has built and led best-in-class functions and teams in companies experiencing major growth. Prior to joining Johnson & Johnson, Dr. Bhattacharyya was a Vice President of Market Access Services at Covance. Prior to joining Covance, Samir was a senior director of marketing at Baxter Healthcare Corporation. Dr. Bhattacharyya also worked for Amgen, Pfizer (Pharmacia), and Procter & Gamble.
Dr. Bhattacharyya’s therapeutic experience includes orthopedic, nephrology, oncology, cardiovascular, sports medicine, urology, and infectious diseases. He has many publications in peer reviewed journals in the field of health economics and outcomes research.
Dr. Bhattacharyya received his PhD in Pharmacoeconomics from the University of Arizona Pharmacy School and MS in Economics from the Eller College of Management at the University of Arizona.
Save This Event
When & Where
JLABS, part of Johnson & Johnson Innovation, LLC, is a network of life science incubators providing emerging companies many of the advantages of being in a big company, without the capital investment. JLABS offers singular bench tops, modular wet lab units and office space on a short-term basis, allowing companies to pay only for the space they need, with an option to quickly expand when they have the resources to do so. Companies residing at JLABS also have access to core research labs hosting specialized capital equipment and shared administrative areas. JLABS is an open innovation model, and the agreement for space does not grant JLABS or Johnson & Johnson Innovation any stake or rights in the companies, nor will the companies have a guaranteed future affiliation with JLABS. The flagship facility is located in San Diego at Janssen's West Coast Research Center, and JLABS has now two established locations in San Francisco - one through a collaboration with the California Institute for Quantitative Biosciences (QB3) and a second standalone facility - one in Boston through a collaboration with Lab Central, one in Houston through a collaboration with TMC, and one in Toronto through a collaboration with MaRS. For more information please visit jlabs.jnjinnovation.com.